$23.080
-0.773 (-3.35%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de VRDN por análisis de gráficos similares
Alphio's VRDN stock price prediction model matches the current Viridian Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $22.25 (-3.61%). The 1-week path is $22.06 (-4.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Viridian Therapeutics Inc?
Viridian Therapeutics (VRDN) appears to be a good buy right now, trading at $23.08 with a forward P/E of 1.0072, indicating potential undervaluation. The recent FDA approval for Lumvoa therapy for thyroid eye disease is a significant positive catalyst, expected to drive revenue growth. However, the current RSI of 38.888 suggests the stock is near oversold territory, which could lead to a rebound. The main risk is the negative net income of -127,119,000 USD reported in Q2 2026, which reflects ongoing financial challenges that investors should monitor closely.
VRDN cerró en $23.08 el Friday, tras bajar -3.35%
Viridian Therapeutics Inc (VRDN) last closed at $23.08, losing -3.35%. These facts feed the 1-day and 1-week VRDN price prediction above.
Factores de la previsión
Los factores de la previsión de Viridian Therapeutics Inc (VRDN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de VRDN, ordenadas por similitud.
Análisis de estacionalidad de VRDN
Historically the probability of a positive August return for VRDN is 0.00%. October offers the highest probability of a positive month at 93.48%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de VRDN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $13.32 | $13.94 | $17.43 | -39.59% |
| Sep 2026 | $8.18 | $11.41 | $13.25 | -50.55% |
| Oct 2026 | $11.92 | $13.50 | $13.82 | -41.51% |
| Nov 2026 | $12.29 | $12.44 | $16.30 | -46.09% |
| Dec 2026 | $11.34 | $13.54 | $17.31 | -41.33% |
En 2026, se proyecta que Viridian Therapeutics Inc (VRDN) oscile entre $8.18 y $17.43.
Previsión mensual de Viridian Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Viridian Therapeutics Inc promedie $13.94, con un mínimo de $13.32 y un máximo de $17.43.
En Sep de 2026, se proyecta que Viridian Therapeutics Inc promedie $11.41, con un mínimo de $8.18 y un máximo de $13.25.
En Oct de 2026, se proyecta que Viridian Therapeutics Inc promedie $13.50, con un mínimo de $11.92 y un máximo de $13.82.
En Nov de 2026, se proyecta que Viridian Therapeutics Inc promedie $12.44, con un mínimo de $12.29 y un máximo de $16.30.
En Dec de 2026, se proyecta que Viridian Therapeutics Inc promedie $13.54, con un mínimo de $11.34 y un máximo de $17.31.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.